Chapter/Section Purchase

1 Study Coverage
1.1 Plasma Protein Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Plasma Protein Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma Protein Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hemophilia
1.3.3 PID
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Plasma Protein Therapeutics Sales Estimates and Forecasts 2017-2028
2.2 Global Plasma Protein Therapeutics Revenue Estimates and Forecasts 2017-2028
2.3 Global Plasma Protein Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Plasma Protein Therapeutics Sales by Region
2.4.1 Global Plasma Protein Therapeutics Sales by Region (2017-2022)
2.4.2 Global Sales Plasma Protein Therapeutics by Region (2023-2028)
2.5 Global Plasma Protein Therapeutics Revenue by Region
2.5.1 Global Plasma Protein Therapeutics Revenue by Region (2017-2022)
2.5.2 Global Plasma Protein Therapeutics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Plasma Protein Therapeutics Sales by Manufacturers
3.1.1 Global Top Plasma Protein Therapeutics Manufacturers by Sales (2017-2022)
3.1.2 Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plasma Protein Therapeutics in 2021
3.2 Global Plasma Protein Therapeutics Revenue by Manufacturers
3.2.1 Global Plasma Protein Therapeutics Revenue by Manufacturers (2017-2022)
3.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Plasma Protein Therapeutics Revenue in 2021
3.3 Global Plasma Protein Therapeutics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Plasma Protein Therapeutics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Plasma Protein Therapeutics Sales by Type
4.1.1 Global Plasma Protein Therapeutics Historical Sales by Type (2017-2022)
4.1.2 Global Plasma Protein Therapeutics Forecasted Sales by Type (2023-2028)
4.1.3 Global Plasma Protein Therapeutics Sales Market Share by Type (2017-2028)
4.2 Global Plasma Protein Therapeutics Revenue by Type
4.2.1 Global Plasma Protein Therapeutics Historical Revenue by Type (2017-2022)
4.2.2 Global Plasma Protein Therapeutics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Type (2017-2028)
4.3 Global Plasma Protein Therapeutics Price by Type
4.3.1 Global Plasma Protein Therapeutics Price by Type (2017-2022)
4.3.2 Global Plasma Protein Therapeutics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Plasma Protein Therapeutics Sales by Application
5.1.1 Global Plasma Protein Therapeutics Historical Sales by Application (2017-2022)
5.1.2 Global Plasma Protein Therapeutics Forecasted Sales by Application (2023-2028)
5.1.3 Global Plasma Protein Therapeutics Sales Market Share by Application (2017-2028)
5.2 Global Plasma Protein Therapeutics Revenue by Application
5.2.1 Global Plasma Protein Therapeutics Historical Revenue by Application (2017-2022)
5.2.2 Global Plasma Protein Therapeutics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Application (2017-2028)
5.3 Global Plasma Protein Therapeutics Price by Application
5.3.1 Global Plasma Protein Therapeutics Price by Application (2017-2022)
5.3.2 Global Plasma Protein Therapeutics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Plasma Protein Therapeutics Market Size by Type
6.1.1 North America Plasma Protein Therapeutics Sales by Type (2017-2028)
6.1.2 North America Plasma Protein Therapeutics Revenue by Type (2017-2028)
6.2 North America Plasma Protein Therapeutics Market Size by Application
6.2.1 North America Plasma Protein Therapeutics Sales by Application (2017-2028)
6.2.2 North America Plasma Protein Therapeutics Revenue by Application (2017-2028)
6.3 North America Plasma Protein Therapeutics Market Size by Country
6.3.1 North America Plasma Protein Therapeutics Sales by Country (2017-2028)
6.3.2 North America Plasma Protein Therapeutics Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Plasma Protein Therapeutics Market Size by Type
7.1.1 Europe Plasma Protein Therapeutics Sales by Type (2017-2028)
7.1.2 Europe Plasma Protein Therapeutics Revenue by Type (2017-2028)
7.2 Europe Plasma Protein Therapeutics Market Size by Application
7.2.1 Europe Plasma Protein Therapeutics Sales by Application (2017-2028)
7.2.2 Europe Plasma Protein Therapeutics Revenue by Application (2017-2028)
7.3 Europe Plasma Protein Therapeutics Market Size by Country
7.3.1 Europe Plasma Protein Therapeutics Sales by Country (2017-2028)
7.3.2 Europe Plasma Protein Therapeutics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Plasma Protein Therapeutics Market Size by Type
8.1.1 Asia Pacific Plasma Protein Therapeutics Sales by Type (2017-2028)
8.1.2 Asia Pacific Plasma Protein Therapeutics Revenue by Type (2017-2028)
8.2 Asia Pacific Plasma Protein Therapeutics Market Size by Application
8.2.1 Asia Pacific Plasma Protein Therapeutics Sales by Application (2017-2028)
8.2.2 Asia Pacific Plasma Protein Therapeutics Revenue by Application (2017-2028)
8.3 Asia Pacific Plasma Protein Therapeutics Market Size by Region
8.3.1 Asia Pacific Plasma Protein Therapeutics Sales by Region (2017-2028)
8.3.2 Asia Pacific Plasma Protein Therapeutics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Plasma Protein Therapeutics Market Size by Type
9.1.1 Latin America Plasma Protein Therapeutics Sales by Type (2017-2028)
9.1.2 Latin America Plasma Protein Therapeutics Revenue by Type (2017-2028)
9.2 Latin America Plasma Protein Therapeutics Market Size by Application
9.2.1 Latin America Plasma Protein Therapeutics Sales by Application (2017-2028)
9.2.2 Latin America Plasma Protein Therapeutics Revenue by Application (2017-2028)
9.3 Latin America Plasma Protein Therapeutics Market Size by Country
9.3.1 Latin America Plasma Protein Therapeutics Sales by Country (2017-2028)
9.3.2 Latin America Plasma Protein Therapeutics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Plasma Protein Therapeutics Market Size by Type
10.1.1 Middle East and Africa Plasma Protein Therapeutics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Type (2017-2028)
10.2 Middle East and Africa Plasma Protein Therapeutics Market Size by Application
10.2.1 Middle East and Africa Plasma Protein Therapeutics Sales by Application (2017-2028)
10.2.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Application (2017-2028)
10.3 Middle East and Africa Plasma Protein Therapeutics Market Size by Country
10.3.1 Middle East and Africa Plasma Protein Therapeutics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Shire (Baxalta)
11.1.1 Shire (Baxalta) Corporation Information
11.1.2 Shire (Baxalta) Overview
11.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Shire (Baxalta) Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shire (Baxalta) Recent Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Overview
11.2.3 CSL Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CSL Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Corporation Information
11.3.2 Grifols Overview
11.3.3 Grifols Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Grifols Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Corporation Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Octapharma Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Kedrion
11.5.1 Kedrion Corporation Information
11.5.2 Kedrion Overview
11.5.3 Kedrion Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Kedrion Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Kedrion Recent Developments
11.6 LFB Group
11.6.1 LFB Group Corporation Information
11.6.2 LFB Group Overview
11.6.3 LFB Group Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 LFB Group Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 LFB Group Recent Developments
11.7 Biotest
11.7.1 Biotest Corporation Information
11.7.2 Biotest Overview
11.7.3 Biotest Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Biotest Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biotest Recent Developments
11.8 BPL
11.8.1 BPL Corporation Information
11.8.2 BPL Overview
11.8.3 BPL Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 BPL Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BPL Recent Developments
11.9 RAAS
11.9.1 RAAS Corporation Information
11.9.2 RAAS Overview
11.9.3 RAAS Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 RAAS Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 RAAS Recent Developments
11.10 CBPO
11.10.1 CBPO Corporation Information
11.10.2 CBPO Overview
11.10.3 CBPO Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 CBPO Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CBPO Recent Developments
11.11 Hualan Bio
11.11.1 Hualan Bio Corporation Information
11.11.2 Hualan Bio Overview
11.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Hualan Bio Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hualan Bio Recent Developments
11.12 Kamada
11.12.1 Kamada Corporation Information
11.12.2 Kamada Overview
11.12.3 Kamada Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Kamada Plasma Protein Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Kamada Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Plasma Protein Therapeutics Industry Chain Analysis
12.2 Plasma Protein Therapeutics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Plasma Protein Therapeutics Production Mode & Process
12.4 Plasma Protein Therapeutics Sales and Marketing
12.4.1 Plasma Protein Therapeutics Sales Channels
12.4.2 Plasma Protein Therapeutics Distributors
12.5 Plasma Protein Therapeutics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Plasma Protein Therapeutics Industry Trends
13.2 Plasma Protein Therapeutics Market Drivers
13.3 Plasma Protein Therapeutics Market Challenges
13.4 Plasma Protein Therapeutics Market Restraints
14 Key Findings in The Global Plasma Protein Therapeutics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer